Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/216541
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBespalov, Daniil-
dc.contributor.authorPino, Dayana-
dc.contributor.authorVidal-Guirao, Sònia-
dc.contributor.authorFranquesa, Júlia-
dc.contributor.authorLopez-Ramajo, Daniel-
dc.contributor.authorFilgaira Enri, Ingrid-
dc.contributor.authorWan, Lin-
dc.contributor.authorO'Sullivan, Paul A.-
dc.contributor.authorLey, Steven C.-
dc.contributor.authorForcales Fernàndez, Sonia-Vanina-
dc.contributor.authorRojas, Juan Jose-
dc.contributor.authorIzquierdo Serra, Mercè-
dc.contributor.authorSoler Prat, Concepció-
dc.contributor.authorManils Pacheco, Joan-
dc.date.accessioned2024-11-15T19:01:32Z-
dc.date.available2024-11-15T19:01:32Z-
dc.date.issued2024-10-03-
dc.identifier.issn2045-2322-
dc.identifier.urihttps://hdl.handle.net/2445/216541-
dc.description.abstractAberrant caspase recruitment domain family member 14 (CARD14) signaling has been strongly associated with inflammatory skin conditions. CARD14 acts as a scaffold protein, ultimately activating the transcription factor NF-KB. Although primarily studied in the context of inflammation, recent research has suggested its potential implications in tumorigenesis. In this study, we gathered The Cancer Genome Atlas (TCGA) tumor data to gauge the involvement of CARD14 in cancer, including genetic alterations, expression patterns, survival correlations, immune cell infiltration and functional interactions across diverse cancer types. We found heightened CARD14 expression in most tumors and there was a significant correlation between CARD14 expression and the prognosis of patients for certain tumors. For instance, patients with higher CARD14 expression had a better prognosis in sarcoma, lung, cervix and head and neck cancers. Moreover, CARD14 expression positively correlated with neutrophil infiltration in most of the cancer types analyzed. Finally, enrichment analysis showed that epithelial development and differentiation pathways were involved in the functional mechanism of CARD14. Our results show that CARD14 may have the potential to become a prognostic biomarker in several cancers, hence, further prospective studies will be required for its validation.-
dc.format.extent14 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherNature Publishing Group-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/s41598-024-74565-4-
dc.relation.ispartofScientific Reports, 2024, vol. 14-
dc.relation.urihttps://doi.org/10.1038/s41598-024-74565-4-
dc.rightscc by-nc-nd (c) Bespalov, D. et al., 2024-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)-
dc.subject.classificationMarcadors bioquímics-
dc.subject.classificationBiologia computacional-
dc.subject.classificationExpressió gènica-
dc.subject.otherBiochemical markers-
dc.subject.otherComputational biology-
dc.subject.otherGene expression-
dc.titleBioinformatic analysis of molecular characteristics and oncogenicfeatures of CARD14 in human cancer-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec751543-
dc.date.updated2024-11-15T19:01:32Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid39362963-
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
870029.pdf3.4 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons